BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:04 PM
Mar 30, 2009
 |  BC Extra  |  Top Story

Arena off after obesity data

Arena (NASDAQ:ARNA) fell $1.27 (28%) to $3.23 on Monday after its lorcaserin met the co-primary endpoints in the Phase III BLOOM trial but achieved only one of two FDA benchmarks for developing obesity compounds. Top-line data from...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >